Esterase-activatable dimeric HDAC inhibitor nanotherapeutics for enhanced lymphoma epigenetic therapy.
Saved in:
| Title: | Esterase-activatable dimeric HDAC inhibitor nanotherapeutics for enhanced lymphoma epigenetic therapy. |
|---|---|
| Authors: | Li T; Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China; Department of Hematology, The First Affiliated Hospital of Ningbo University, 59 Liuting Road, Ningbo, Zhejiang 315010, China., Zhuang W; Department of Hematology, Lianyungang Second People's Hospital, Lianyungang, Jiangsu 222000, China., Fan S; Department of Hematology, The First Affiliated Hospital of Ningbo University, 59 Liuting Road, Ningbo, Zhejiang 315010, China., Yi P; Department of Research, Wuhan Kindstar Medical Laboratory Co. Ltd., 666 Gaoxin Avenue, Wuhan, Hubei 430060, China., Ouyang G; Department of Hematology, The First Affiliated Hospital of Ningbo University, 59 Liuting Road, Ningbo, Zhejiang 315010, China. Electronic address: fyyouyangguifang@nbu.edu.cn., Qian W; Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China. Electronic address: qianwb@zju.edu.cn. |
| Source: | Colloids and surfaces. B, Biointerfaces [Colloids Surf B Biointerfaces] 2026 May; Vol. 261, pp. 115416. Date of Electronic Publication: 2026 Jan 08. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9315133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4367 (Electronic) Linking ISSN: 09277765 NLM ISO Abbreviation: Colloids Surf B Biointerfaces Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
